London doctor hails Canada’s first drug that slows Alzheimer’s disease

A newly approved medication that slows the progression of Alzheimer’s disease is being called “groundbreaking” by a London doctor involved in its development.

Michael Borrie, physician and medical director of the Aging and Memory Clinic at St. Joseph’s Health Care London, said Health Canada’s approval of lecanemab – the first medication shown to stall dementia in people with early-stage Alzheimer’s – is the “most critical change” in combatting the disease in the last 25 years.

Recommended Videos

“I think this is a very important moment where we finally have a medication that can actually alter the underlying disease process in the brain,” Borrie said.

Borrie said the newly approved drug, already available in more than 50 countries, represents the first time there’s been “anything tha